Palvella Therapeutics (PVLA) Times Interest Earned (2014 - 2024)

Palvella Therapeutics (PVLA) reported Times Interest Earned of -$24.12 for Q4 2024, down 4.83% quarter-over-quarter from -$23.01 in Q3 2024.

Palvella Therapeutics (PVLA) Times Interest Earned (2014 - 2024) Analysis & Trends

Palvella Therapeutics (PVLA) has 3 years of Times Interest Earned data on file, last reported at -$24.12 in Q4 2024.

Times Interest Earned for Q4 2024 came in at -$24.12, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was -$174.94 (down 1291.14% YoY), and the FY2024 annual result was -$32.78, changed N/A from the prior year.
Times Interest Earned declined to -$24.12 in Q4 2024 per PVLA's latest filing, from -$23.01 in the prior quarter.
Over five years, Times Interest Earned peaked at -$23.01 in Q3 2024 and troughed at -$100.28 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	3.58
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	11.50
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-258.33
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	547.67
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	11.79
10	Palvella Therapeutics	1.49 Bn	1.23 Bn	-	-

Download Data